Back to all people

Yang Yang

FDA/CDER

3 appearances in the program

Sessions & presentations

PS44: Co-Development of Single or Multi-Target Therapies in Combination: Statistical, Clinical, and Regulatory Issues in Trial Designs

Parallel · Fri, Sep 26 , 1:30 PM

Co-Organizer

PS44: Co-Development of Single or Multi-Target Therapies in Combination: Statistical, Clinical, and Regulatory Issues in Trial Designs

Presentation: 21 CFR 300.50 and Beyond: Statistical and Regulatory Considerations in the Development of Combination Therapies

Parallel · Fri, Sep 26 , 1:30 PM

Presenting Author

PS44: Co-Development of Single or Multi-Target Therapies in Combination: Statistical, Clinical, and Regulatory Issues in Trial Designs

Presentation: Panelist Discussion

Parallel · Fri, Sep 26 , 1:30 PM

Panelist

↑